Kolexia
Preudhomme Claude
Pharmacien
Hôpital Albert Calmette
Lille, France
424 Activités
4 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie résiduelle Syndromes myélodysplasiques Leucémie myéloïde chronique BCR-ABL positive Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie myélomonocytaire chronique Prédisposition génétique à une maladie

Industries

Astellas
13 collaboration(s)
Dernière en 2023
Abbvie
10 collaboration(s)
Dernière en 2023
Servier
6 collaboration(s)
Dernière en 2023
Amgen
4 collaboration(s)
Dernière en 2020

Dernières activités

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Leukemia   17 février 2024
Prognostic impact of CEBPA mutational subgroups in adult AML.
Leukemia   16 janvier 2024
Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Tetraspanin CD81 Supports Cancer Stem Cell Function and Represents a Therapeutic Vulnerability in Acute Myeloid Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Hyperleukocytosis Increases the Risk of Early Relapses Independently of Genetics in AML
65th ASH Annual Meeting Abstracts   02 novembre 2023
Impact of Residence in an Agricultural Zone on AML Characteristics
65th ASH Annual Meeting Abstracts   02 novembre 2023
Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
65th ASH Annual Meeting Abstracts   02 novembre 2023
Chromothripsis and Genomic Complexity As Pejorative Prognostic Markers in Pediatric and Adult T-ALL
65th ASH Annual Meeting Abstracts   02 novembre 2023
Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clonal Dynamics of FLT3-ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin
65th ASH Annual Meeting Abstracts   02 novembre 2023